The rules of attraction

Nature

Volumn 425, Issue 6956, 2003, Pages 357-359

  Neckers, Len ^a   Lee, Yong Sok ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

17 ALLYLAMINOGELDANAMYCIN; GELDANAMYCIN; HEAT SHOCK PROTEIN 90; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; 17 ALLYLAMINO 17 DEMETHOXYGELDANAMYCIN; 17-(ALLYLAMINO)-17-DEMETHOXYGELDANAMYCIN; ANTINEOPLASTIC AGENT; BENZOQUINONE DERIVATIVE; DRUG DERIVATIVE; MACROCYCLIC LACTAM; RIFABUTIN;

ATTRACTANT;

BINDING AFFINITY; CANCER CELL; CELL KILLING; DRUG BINDING; DRUG PROTEIN BINDING; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; SHORT SURVEY; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; ENZYME SPECIFICITY; METABOLISM; NEOPLASM; NOTE; PROTEIN BINDING; PROTEIN CONFORMATION;

ANIMALS; ANTINEOPLASTIC AGENTS; BENZOQUINONES; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LACTAMS, MACROCYCLIC; NEOPLASMS; PROTEIN BINDING; PROTEIN CONFORMATION; RIFABUTIN; SUBSTRATE SPECIFICITY;

EID: 0141509074     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/425357a     Document Type: Short Survey

References (11)

1. Ferrarini, M., Heltai, S., Zocchi, M.R. & Rugarli, C. Int. J. Cancer 51, 613-619 (1992).
2. Kamal, A. et al. Nature 425, 407-410 (2003).
3. Ritossa, F. Cell Stress Chaperones 1, 97-98 (1996).
4. Maloney, A. & Workman, P. Expert Opin. Biol. Ther. 2, 3-24 (2002).
5. Chiosis, G. et al. Chem. Biol. 8, 289-299 (2001).
6. Scheibel, T. & Buchner, J. Biochem. Pharmacol. 56, 675-682 (1998).
7. Banerji, U. et al. Proc. 93rd Ann. Meet. Am. Assoc. Cancer Res. 43, A1352 (2002).
8. Jez, J. M., Chen, J., Rastelli, G., Stroud, R. M. & Santi, D. V. Chem. Biol. 10, 361-368 (2003).
9. Rinehart, K. L. & Shields, L. S. Fortschr. Chem. Org. Naturstoffe 33, 231-307 (1976).
10. Panaretou, B. et al. Mol. Cell 10, 1307-1318 (2002).
11. Riggs, D. L. et al. EMBO J. 22, 1158-1167 (2003).